UBS Group’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$104K Buy
26,903
+21,740
+421% +$53.4K ﹤0.01% 6981
2025
Q4
$10.1K Buy
5,163
+4,693
+999% +$7.7K ﹤0.01% 8244
2025
Q3
$397 Sell
470
-15,850
-97% -$11.6K ﹤0.01% 9694
2025
Q2
$11.8K Sell
16,320
-5,450
-25% -$4.09K ﹤0.01% 8766
2025
Q1
$18.7K Sell
21,770
-25,460
-54% -$37.8K ﹤0.01% 8279
2024
Q4
$79.3K Buy
47,230
+19,449
+70% +$46.5K ﹤0.01% 7013
2024
Q3
$79.2K Buy
27,781
+7,628
+38% +$19.7K ﹤0.01% 6517
2024
Q2
$47.2K Sell
20,153
-31,434
-61% -$82.1K ﹤0.01% 6733
2024
Q1
$152K Sell
51,587
-5,143
-9% -$14.6K ﹤0.01% 6029
2023
Q4
$170K Buy
56,730
+28,999
+105% +$83K ﹤0.01% 5877
2023
Q3
$87.6K Sell
27,731
-2,833
-9% -$9.22K ﹤0.01% 5916
2023
Q2
$118K Buy
30,564
+13,251
+77% +$38.2K ﹤0.01% 5868
2023
Q1
$48K Buy
17,313
+2,864
+20% +$6.01K ﹤0.01% 6491
2022
Q4
$26K Buy
+14,449
New +$27.9K ﹤0.01% 7387
2022
Q2
Sell
-804
Closed -$3K 10705
2022
Q1
$3K Sell
804
-4,827
-86% -$19.8K ﹤0.01% 9464
2021
Q4
$30K Sell
5,631
-31,682
-85% -$170K ﹤0.01% 7403
2021
Q3
$229K Buy
+37,313
New +$297K ﹤0.01% 5216
2020
Q4
Sell
-147
Closed -$2K 8617
2020
Q3
$2K Buy
+147
New +$1.57K ﹤0.01% 7676

Other funds holding NAUT